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Synaptic plasticity of glutamatergic transmission is thought to be the cellular basis
for learning and memory. However, the precise mechanisms that regulate the induction
of plasticity are not currently understood. In the CA1 region of the hippocampus, the
peptide hormone, PACAP (pituitary adenylate cyclase activating polypeptide) acting
through the PAC1 receptor (PAC1R) initiates a cascade intracellularly which regulates Nmethyl D-aspartate receptor (NMDAR) function, facilitating long term potentiation
(LTP). We predicted that endogenous PACAP is active following high frequency
stimulation during extracellular recordings from rat and mouse hippocampal slices and
will lower the threshold for induction of LTP. Data from PACAP knock-out mice
support this hypothesis; however pharmacological manipulation of LTP by PACAP was
variable. Our data suggest the PAC1R couples to two pathways with opposing effects on
NMDAR function; the NMDAR attenuating arm can be blocked by a phosphatase
inhibitor resulting in a more robust enhancement of NMDAR function by PACAP.
Key Words: PACAP, NMD A, metaplasticity, synaptic plasticity, LTP, Src
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Section 1

INTRODUCTION
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1.1 General Introduction
Synaptic plasticity is widely believed to be the cellular basis for learning and
memory; however the mechanisms which regulate synaptic plasticity are poorly
understood. Metaplasticity, the “plasticity of plasticity” refers to any mechanism that can
alter the threshold for induction of plasticity but does not alter synaptic efficacy by itself
(Abraham & Bear, 1996). These mechanisms could potentially have huge effects on
behaviour. One neuropeptide that has been shown to alter the threshold for induction of
synaptic plasticity is pituitary adenylate cyclase activating polypeptide (PACAP), which
has the ability to signal through both Gas and Gaq (G-proteins) (Yaka et al., 2003;
MacDonald et al., 2005). In humans, certain polymorphisms of the PACAP gene have
been associated with schizophrenia, poorer memory performance, decreased hippocampal
volume and major depressive disorder (Hashimoto et ah, 2007; Hashimoto et ah, 2010).
In addition, PACAP knock-out mice have been proposed as a potential animal model for
schizophrenia, display memory deficits and depression-like behaviour (Hashimoto et ah,
2007; Otto et ah, 2001; Hashimoto et ah, 2009). Polymorphisms of the PACAP gene and
its PAC1 receptor (PAC1R) are potential risk factors for a variety of major mental
disorders (Hashimoto, 2007; Hashimoto, 2010). Thus, further research into this
important neuropeptide and specifically how it is able to alter synaptic plasticity is
necessary.
I begin with an introduction on the synapse and the role N-methyl D-aspartate
receptors (NMDARs) play in excitatory neurotransmission. The structure and function of
G-protein coupled receptors (GPCRs) is outlined, focussing on the PAC1R, continuing
with a look at the role of NMDARs, phosphatases, kinases and GPCRs in metaplasticity
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of excitatory synaptic transmission in the hippocampus. Results are presented
demonstrating that two pathways, having opposing effects on metaplasticity, can be
activated by the PAC1R. Moreover, I present evidence that endogenous PACAP
contributes to plasticity at high frequencies. Finally, these results are discussed in terms
of how they contribute to our understanding of GPCRs and metaplasticity.

1.2 Synaptic Transmission
In the vertebrate nervous system, neurons communicate by forming synapses
composed of a presynaptic and postsynaptic cells. A single cell receives anywhere from
10, 000 to 30,000 connections from other cells (Malenka & Nicoll, 1999). A synapse
consists of a presynaptic bouton, a space known as the synaptic cleft and usually a
postsynaptic dendritic spine, although synapses do not always require a dendritic spine.
A dendritic spine is a mushroom shaped protrusion from the dendritic shaft, 1-3 pm long
and 1pm in diameter (Kennedy, 2000). The pre and post synaptic cells are actually held
together by tiny microfilaments and encased by glia (Gamer et al., 2000; Malenka &
Nicoll, 1999).
The specialized region of the presynaptic membrane that contributes to the
synapse is known as the active zone (Gamer et al., 2000). When an action potential
occurs in the presynaptic cell calcium enters through voltage-gated calcium channels.
This calcium signal triggers the action of a variety of proteins responsible for causing
synaptic vesicles containing neurotransmitter to fuse with the cell membrane and release
neurotransmitter into the synaptic cleft. This entire presynaptic process takes a mere
lOOps (Rizo & Rosenmund, 2008). The neurotransmitter then traverses the synaptic cleft
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to come in contact with the postsynaptic membrane. The area of the postsynaptic
membrane that contributes to the synapse is known as the post synaptic density (PSD).
This is a protein rich area, visible under the electron microscope as a protrusion or
thickening of the membrane, containing a high density of ion channels and receptors
ready to respond to neurotransmitters. The PSD is dynamic and contains a large number
of scaffolding proteins and down-stream effectors with the ability to alter the strength of
the synapse (Kennedy, 2000). Finally, the neurotransmitter usually re-enters the
presynaptic cell by the process of reuptake and is repackaged in synaptic vesicles ready to
be released in response to the next calcium signal (Werner & Covenas, 2010).

1.3 Excitatory Neurotransmission
The vast majority of synapses are glutamatergic excitatory synapses in which the
postsynaptic cell becomes depolarized in response to the release of the neurotransmitter
glutamate from the presynaptic cell. The depolarization is caused by the flow of sodium
(Na+) into the cell through ligand or voltage gated ion channels. The resulting brief
depolarization of the postsynaptic cell is known as an excitatory postsynaptic potential
(EPSP) (Kennedy, 2000). In order for an action potential to occur, multiple EPSPs must
summate either spatially (various synapses across the postsynaptic cell firing in
synchrony) or temporally (rapid firing of a single synapse). The axon-hillock is an area
of the cell which has a high density of voltage-gated channels and the smallest threshold
of any site for action potential initiation, if it reaches a certain threshold of depolarization
an action potential will be propagated down the axon (Hausseret al., 2000; Fry & Jabr,
2010).
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1.4 Glutamate Signalling
Once released into the synaptic cleft glutamate can act on postsynaptic receptors,
presynaptic receptors (autocrine signalling) or on nearby cells (paracrine signalling).
Glutamate remains intact in the synapse; capable of interacting with receptors until it
diffuses away or is actively cleared from the synapse by excitatory amino acid
transporters (EAAT) (Featherstone, 2010). For the purposes of this thesis, I will focus on
postsynaptic glutamate receptors. Glutamate receptors can be divided into two main
classes: ionotropic and metabotropic. Metabotropic glutamate receptors are GPCRs,
which act via signalling cascades within the post synaptic cell in response to glutamate
binding. There are eight metabotropic glutamate receptors which can be further classified
into three groups based on their activity: group I (mGluRl, mGluR5), group II (mGluR2,
mGluR3) and group III (mGluR4, mGluR6, mGluR7, mGluR8) (Conn & Pin, 1997;
Featherstone, 2010). Ionotropic glutamate receptors can be subdivided based on their
respective agonists: a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor
(AMPAR), N-methyl D-aspartate receptor (NMDAR) and kainate receptor. These
receptors are all tetrameric ion channels that open in response to the binding of glutamate
and allow for the flow of ions into and out of the cell (Dingledine et al., 1999;
Featherstone, 2010) (see Figure 1.1). AMPAR and NMDAR will be discussed further.

1.5 AMPAR
AMPARs are responsible for nearly all fast excitatory transmission in the
vertebrate central nervous system. They are also the main contributors to the EPSP
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A

Figure 1.1 Schematic of a glutamatergic synapse between two pyramidal neurons A. the
red circles represent synaptic vesicles in three different pools reserve (R), proximal (P)
and docked (D). AZ indicates the active zone (from Gamer et al., 2000). B. Glutamate
(Glu) is packaged into synaptic vesicles before being released and acting on metabotropic
(mGluR) and ionotropic (iGluR) receptors (from Featherstone, 2010).
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generated in response to the presynaptic release of glutamate, although NMDARs may
have a small contribution (Kennedy, 2000). AMPARs, like all other ionotropic
glutamate receptors are tetrameric. They are typically composed of at least two variants
of the GluAl-4 subunits but have on rare occasions been observed as homotetrameric
(Nakagawa, 2010). Each subunit has an extracellular N-terminus, an intracellular Cterminus, 3 transmembrane domains and one cytoplasmic re-entrant loop located between
transmembrane domains 1 and 3 (Dingledine et al., 1999). Upon the binding of
glutamate to the ligand binding domain, located extracellularly, the receptor undergoes a
conformational change and allows for the passive flow of monovalent cations through its
channel pore (Nakagawa, 2010; Featherstone, 2010). A Na+ influx and K+ efflux via
AMPARs is the main driving force behind most EPSPs (Kennedy, 2000). AMPAR which
lack the GluR2 subunit are also permeable to calcium (Essin et al., 2002).
AMPARs are constantly being cycled between cytoplasmic compartments and the
plasma membrane. Phosphorylation/dephosphorylation of certain sites on the C-terminal
tail of the GluAl subunit can affect channel conductance, and the rate of receptor
trafficking to the plasma membrane (Man et al., 2007; Derkach et al., 1999).

1.6 NMDAR
NMDARs are expressed nearly everywhere within the central nervous system.
NMDARs are similar to AMPARs in that they are also tetrameric and undergo a
conformational change in response to the binding of glutamate (Featherstone, 2010).
Unlike AMPARs, NMDARs also require the presence of the co-agonist glycine or Dserine for efficient pore opening (Schell et al., 1995; Hirai et al., 1996; Schell et al.,
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1997). The NMDAR requires the occupation of all four of its agonist binding sites to
open (Paoletti, 2011) (see Figure 1.2 B). Once the NMDAR is in the open configuration
the channel pore is quickly blocked by magnesium (Mg ), which binds to the Mg
binding site inside the channel pore and prevents the flow of ions (Macdonald et al.,
1982; Mayer et al., 1984; Nowak et al., 1984). Mg2+ is only ejected from the NMDAR
channel pore once a certain threshold of depolarization is reached, giving NMDARs
strong voltage dependence (Anotov & Johnson, 1999). This threshold is too great to be
achieved by the singular action of AMPARs at one synapse. In order to reach this
threshold, depolarization must summate spatially, temporally or via back-propagating
action potentials (Kennedy, 2000). It is for this reason that NMDARs have been referred
to as “co-incident detectors”, because they require simultaneous chemical and electrical
signals (Kemp & McKeman, 2002).
Once the Mg2+ is relieved from the pore of the NMDAR, similar to AMPAR, an
influx of Na+ and efflux K+ occurs however, unlike AMPARs, NMDARs always allow
for the influx of calcium (Ca ) (Lynch et al., 1983). This local increase in Ca

acts on a

number of downstream effectors and is vitally important in the induction of NMDAR
dependent synaptic plasticity (Zhang et al., 1998). NMDARs are considered very slow in
comparison to rapid AMPA or kainite receptors, they have a slow EPSC rise time and
closing a speed of several hundred milliseconds (Jahr, 1992; Lester et al., 1990; Wyllie et
al., 1998).

1.7 NMDAR subunits
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There are three families of NMDAR subunits GluNl, GluN2 (A-D) and GluN3
(A-B). NMDARs are similar to AMPAR subunits in terms of their structure: an
extracellular N-terminus, 3 transmembrane domains (Ml, M3. M4), a re-entrant loop
(M2) between transmembrane domain 1 and 3 and finally an intacellular C-terminus, with
M2 forming the pore (Wood et al., 1995; Kuner, et al., 1996). GluNl subunits come in
eight splice variants which differ in agonist affinity, pH sensitivity, zinc (Zn2+)
modulation, and regulation by protein kinase C (PKC) (Sun et al., 1998). The different
GluN2 subunits are the result of four different genes (Paoletti, 2011). The two GluN3
variants differ in the presence or absence of a 60 base-pair insertion in the C-terminus
(Sun et al., 1998). NMDAR are composed of two obligatory GluNl subunits and two
variable GluN2 or GluN3 subunits. The glycine binding site resides on the GluNl
subunit, while the glutamate binding site resides on the GluN2 subunit (Furukawa et al.,
2005). Within the hippocampus NMDARs are primarily diheteromeric GluNl/GluN2A
or GluNl/GluN2B, but can also be found in the triteteromeric configuration
GluNl/GluN2A/GluN2B (Yashiro et al., 2008). Subunit composition affects the
properties of the receptor and also which downstream effectors it may couple to.
The ratio of GluN2A containing NMDARs to GluN2B containing receptors
undergoes a developmental shift. Early in development the hippocampus consists
predominantly of GluN2B containing NMDARs. As development progresses the ratio of
GluN2A containing receptors increases. This increase can be retarded with sensory
deprivation. In the mature hippocampus, GluN2A containing NMDARs are found more
synaptically whereas GluN2B containing receptors are more extrasynaptic. However the
ratio of NMDAR subtypes is by no means static in the mature hippocampus, it is subject
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to alteration by sensory experience and synaptic plasticity (Yashiro et al., 2008).
Activation of GluN2A containing receptors has been linked to neuroprotection, while
activation of GluN2B containing receptors has been linked to excitotoxicity (Liu et al.,
2007).
GluN2A and GluN2B containing receptors have been found to differ in terms of
location (mentioned above), open probability, deactivation, peak current, rise time, decay
time, charge transfer, Ca2+ current, and Ca2+/calmodulin dependant protein kinase II
(CaMKII) binding (Yashiro et al., 2008). The intracellular C-terminal tails of GluN2A
and GluN2B containing receptors are quite long in comparison to other glutamate
receptor subunits, measuring 630 and 650 amino acids, respectively. These tails contain
25 tyrosine residues; possible sites for phosphorylation resulting in the modulation of
channel properties (Salter & Kalia, 2004) (see Figure 1.2 A). The composition of the Cterminal tails also determines which signalling molecules the receptor will interact with,
such as the Src family kinases, Src and Fyn, which play a role in modulating the
threshold for induction of synaptic plasticity (Salter & Kalia, 2004). For these reasons
the two receptor subtypes are thought to play very different roles in the induction of
synaptic plasticity.

1.8 The Postsynaptic Density and the NMDAR complex
NMDARs are found in a protein rich area of the postsynaptic membrane known as
the postsynaptic density (PSD), described previously. A great deal of their function can
be attributed to their association with proteins in the PSD, in fact genetically
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A.

B.

Rest

Closed

Open

Figure 1.2 Schematic of an NMDAR A. Schematic illustrating the length of the GluN2
cytoplasmic tails and their phosphorylations sites (from Salter & Kalia, 2004) B.
Schematic illustrating the glycine and glutamate binding sites as well as the resting,
closed and open configurations (from Featherstone, 2011).
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modified mice with NMDARs missing the long C-terminal tail of certain subunits display
many of the same behavioural abnormalities as mice harbouring a targeted deletion of
that particular subunit, even though gating and cation permeability of the receptors
remains unchanged (Sprengel et al., 1998). This finding illuminates the importance of
NMDAR association with proteins in the PSD via the long C-terminal tail of the
NMDAR subunits.
Most recent models of synaptic transmission view receptors as components of
multi-protein complexes; the NMDAR is no exception (Pawson & Scott, 1997).
Proteomic analysis of the NMDAR revealed 77 proteins which make up what is known as
the NMDAR complex (NRC) (Husi et ah, 2000). The specific composition of the NRC is
largely determined by subunit make-up of the particular receptor (Sans et ah, 2000). The
function of this complex seems to be to anchor the NMDAR in the postsynaptic
membrane and to keep modulators of NMDAR activity and downstream effectors in
close proximity to the receptor and to incoming Ca

signals (Husi et ah, 2000).

CaMKII is a part of the NRC which is necessary for synaptic plasticity. CaMKII
binds to the C-terminal tails of GluN2 subunits (Kennedy, 2000). Ca

diffuses quickly

once it enters the cell, but the NRC overcomes this problem by organizing Ca

sensitive

kinases and phosphatases, such as CaMKII in a micro-domain in close proximity to the
Ca2+ pore (Sprengel et ah, 1998; Husi et ah, 2000; Kennedy, 2000).
Membrane associated guanylate kinases (MAGUKs) are a family of proteins
which bind the NMDAR via the cytoplasmic subunit tails to a series of proteins with
structural and signalling functions within the NRC (Komau et ah, 1995; Sans et ah,
2000). PSD-95 is a member of the MAGUK family and PSD-95 knock-out mice display
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impaired synaptic plasticity as well as impaired learning (Migaud et al., 1998). GluN2A
and GluN2B containing receptors display a preference for certain members of the
MAGUK family (Sans et al., 2000). As illustrated by these two examples, members of
the NRC are just as important for proper NMDAR function as the channel pore itself.

1.9 GPCRs
Cells do not necessarily need to communicate via the flow of ions; another kind of
cell-cell communication is achieved through GPCRs. GPCRS are heptahelical, meaning
that they have seven helical membrane spanning segments which make up the core
domain; these segments are connected by three intracellular and three extracellular loops.
GPCRs may dimerize, but are more often found alone (Bockaet & Pin., 1999). The
receptor is bound to a heterotrimeric G-protein which can be divided into three segments:
a, P and y. In the inactive state guanosine diphosphate (GDP) is bound to the Ga subunit.
Upon ligand binding, the receptor undergoes a conformational change that catalyses the
exchange of GDP for guanosine triphosphate (GTP) on the Ga subunit. The Ga-GTP and
the GPy dimers then dissociate from the receptor and are free to act on downstream
effectors (Cabrere-Vera et al., 2003). G-proteins are classified based on their Ga subunit:
Gas, Gai/o, Gaq and G a l2/13 (see Figure 1.3 A). GPCRs can also be grouped into 6
families based on their associated ligands (Neves et al., 2002; Bockaert & Pin, 1999).
For the purposes of this thesis, Gas and Gaq coupled receptors will be focused on.
Gas coupled GPCRs activate adenylate cyclase (AC) and cyclic adenosine
monophosphate (cAMP) as well as a number of other signalling pathways (Neves et al.,
2002). In contrast Gaq coupled receptors stimulate phospholipase C P (PLCP) to produce
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inositol triphosphate (IP3), which releases Ca2+ from internal stores and diacylglycérol
(DAG) which activates PKC (Neves et al., 2002).

1.10 PACAP
In 1989 a novel 38 amino acid, C-terminally a-amidated peptide was isolated
from ovine hypothalamus based on its ability to stimulate AC in rat anterior pituitary
cells. This peptide was named PACAP38 (pituitary adenylate cyclase activating
polypeptide with 38 residues) (Miyata et al., 1989). The sequence of PACAP38 has
proven to be remarkably well conserved across species, with the initially isolated ovine
PACAP38 being identical to human PACAP 38, suggesting it must have one or more
important physiological functions (Vaudry et al., 2009; Kimura et al., 1989). The side
fractions from the original experiment which lead to the discovery of PACAP38 were
also analyzed and a shorter peptide displaying homology to the N-terminal region of
PACAP38 was discovered which seemed to possess the same ability to stimulate AC, this
peptide was titled PACAP27 (pituitary adenylate cyclase activating polypeptide with 27
residues). The N-terminal region of these peptides shows 68% homology to vasoactive
intestinal peptide (VIP), a peptide isolated in 1970 from porcine intestine based on its
ability to increase peripheral blood flow and decrease arterial pressure in dogs, however
both PACAP38 and PACAP27 have a 1000 times greater ability to stimulate AC than
VIP (Miyata et al., 2010; Miyata et al., 1989; Miyata et al., 1990). Today, these peptides
are all part of the vasoactive intestinal peptide-secretin-growth hormone-releasing
hormone-glucagon super family (Vaudry et al., 2009).
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In humans, the adenylate cyclase activating polypeptide 1 gene (ADCYAP1)
found on chromosome 18 encodes PACAP. The gene is composed of five exons with,
the sequence of PACAP being present on exon 5 (Vaudry et al., 2009). Notably, this
chromosome has been associated with psychiatric disorders such as schizophrenia
(Hashimoto et al., 2007). The human cDNA encodes a 176 amino acid prepro-protein,
with the sequence of PACAP38 or the truncated PACAP27 located at the C-terminal end.
This precursor also encodes a 29 amino acid protein known as PACAP-related-protein
(PRP), which shows only 22% homology to PACAP27 (Vaudry et al., 2009).
PACAP is located widely throughout the brain and peripheral tissues having a
vast number of downstream effects including but not limited to: control of
neurotransmitter release, vasodilation, bronchodilation, activation of intestinal motility,
immune modulation, increase in insulin and histamine secretion and stimulation of stem
cell proliferation/differentiation (Vaudry et al., 2009). PACAP 38 is much more
prevalent than PACAP27, which makes up less than 10% of the peptide content of the
brain, for this reason, for the remainder of this thesis PACAP38 will simply be referred to
as PACAP.

1.11 PA CAP Receptors
PACAP and VIP act on three GPCRs known as VPAC1, VPAC2 and PAC1R
(Harmar et al., 1998). The VP AC receptors have equal affinity for VIP and PACAP, and
differ in their affinity for heloderm, a peptide isolated from the venom of the Gila
monster able to stimulate AC and cAMP; VPAC2 is the heloderm-preferring of the two
VP AC receptors (Rauffrnan et al., 1982; Dickson & Finlayon, 2009). The PAC1R
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receptor is known as a Type I PACAP binding site due to its higher affinity for PACAP
than for VIP (PACAP = 0.5nM, VIP > 500mM; binding affinity Kd), while the VPAC
receptors are Type II binding sites based on their equal affinity for PACAP and VIP
(PACAP = VIP = InM; binding affinity A'd) (Vaudry et al., 2000). These three receptors
are all members of the BI group of GPCRs, having a >120 amino acid long, extracellular
N-terminal domain, that in combination with the three extracellular loops forms the
ligand binding domain. All members of this group can be Gas coupled and stimulate AC
and cAMP (Pisenga & Wank, 1993; Dickson and Finlayson). The PAC1R and VPAC
receptors may also couple to Gaq and the VPAC receptors may additionally coupled to
Gai, making them capable of stimulating a wide number of signalling cascades
depending on the intracellular machinery present (Dickson & Finlayson, 2009). All three
receptors are expressed widely throughout the central nervous system and periphery
however VPAC1 and 2 receptors display a complementary distribution; when they are
expressed within the same structure they are restricted to different layers/areas (Dickson
& Finlayson, 2009).
Most GPCRs do not contain any introns, leaving no opportunity for splice
variants, which slightly alter the function of the receptor. However the PAC1R has more
splice variants than most other GPCRs known (Dautzenberg et al., 1999). Until recently,
it was thought that the VPAC receptors did not possess any splice variants however that
has turned out not to be the case. The VPAC receptor splice variants are as follows:
VPAC1-5TM, VPAC2-5TM (Bokaei et al., 2006), VPAC2de367-380 (Grinninger et al.,
2004), VPAC2de325-438(i325-334) (Miller et al., 2006), and VIPs (Teng et al., 2001).
The PAC1R has 15 currently known splice variants. Hip and hop refer to two 28 amino
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acid cassettes in the third intracellular loop, which seem to affect agonist potency. The
PAC1R splice variants are as follows: PAC1 -short (Pantaloni et ah, 1996), PAC1short,hopl (Braas and May, 1999), PAC1-TM4 (Chatterjee et ah, 1996), PACl-vs
(Dautzenberg et ah, 1999), PACl-3a (Daniel et ah, 2001), PACl-hip, PACl-hopl,
PACl-hop2 (Spengler et ah, 1993), PACl-hiphopl (Joumot et ah, 1995), PACl-hiphop2,
PAC1-55, PACl-85hop, PACl-85hip, PACl-85,6hip and PACl-85,6,16,17 (Lutz et ah,
2006) (see Figure 1.3 B). In rats PAC1-short and PACl-hop are the major variants
expressed in the brain (Zhou et ah, 2000). All these splice variants were identified in cell
lines and have not been studied extensively in vivo, in humans SV-1 and SV-2 are
homologous to hip and hop and the ‘PACl-null’ variant is the most widely expressed in
the brain (Dickson and Finlayson, 2009).
This thesis focuses on the PAC1R. Maxadilan was the first PAC1R specific
agonist isolated from the salivary gland of sand flies, bearing no homology to PACAP or
VIP whatsoever (Lemer et ah, 1991; Moro & Lemer, 1997). By deleting amino acids
25-41 from maxadilan it can be transformed into a specific antagonist, known as M65
(Moro et ah, 1999). Also, deleting amino acids 1-5 from PACAP38 produces a potent
but non-specific antagonist known as PACAP 6-38 (Robberchert et ah, 1992).

1.12 PACAP and PAC1R Transgenic Mice
The lack of low-molecular weight non-peptide PACAP receptor ligands has been
the driving force behind the generation of a variety of transgenic mice (Hashimoto et ah,
2006; Dickson & Finlayson, 2009). While PACAP can cross the blood-brain barrier,
when injected into the blood stream it has a half-life of only 2-10 minutes (Dogrukok-Ak,
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Schematic of the PAC1R illustrating several (but not all) of the different splice variants
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et al., 2003; Vaudry et al., 2000). Several lines of PACAP knock-out (KO) mice were
generated around the same time (Gray et al., 2001; Hashimoto et al., 2001; Hamelink et
al., 2002). Selective KOs and mice over-expressing the PAC1R have also been generated
(Jamen et al., 2000; Otto et al., 2001; Lang et al., 2006). These transgenics have been
found to have a multitude of deficits including, hyperactive psychomotor behaviour,
increased mortality rates, problems with energy homeostasis, and decreased reproductive
function to name just a few.
PAC1R KO mice display many of the same behavioural abnormalities observed in
mouse models of schizophrenia and these abnormalities can be relieved with an atypical
antipsychotic. This is one of the reasons why PACAP has been proposed as a candidate
gene for schizophrenia in humans (Hashimoto et al., 2007). For the purposes of this
thesis we will focus solely on the memory deficits present in these transgenics. PAC1R
KOs display no deficit in the Morris water maze; however they do display deficits in fear
conditioning. Both tasks are, at least in part, hippocampal memory dependant (Sauvage
et al., 2000). This same pattern of preserved water maze performance but deficits in fear
conditioning was observed in mice in which PACIRs were only inactivated in olfactory
bulbs, forebrain and hippocampus. Mossy fibre LTP was also impaired in these mice
(Otto et al., 2001). In vivo, LTP in the dentate gyrus has also been observed to be
impaired in heterozygous PACAP deficient animals (PACAP+/-) and in PAC1R KOs
(Matsuyama et al., 2003). PACAP is homologous to the amnesiac gene in drosophila
which affects memory retention (Hashimoto et al., 2002). Genetic manipulation of the
PACAP system has been shown to affect hippocampal memory in a number of
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experimental paradigms and has also been associated with psychological conditions such
as schizophrenia, of which memory impairment is a symptom (McDowd et al., 2011).

1.13 The Hippocampus
The hippocampus is a brain structure which has long been thought to play a role
in learning and memory. Some of the strongest evidence for this theory came in the early
1950s when 27-year-old, Henry Molaison (patient HM) underwent a temporal lobe
resection, removing at least the anterior 2/3rds of his hippocampus, to control seizures.
Although the operation was successful in terms controlling his seizures, Henry was not
able to form any new declarative memories following the operation (Scoville & Milner,
1957). Similar patterns of memory loss are observed following hippocampal damage by
means of stroke or sclerosis; however skill, habit, classical conditioning and priming
memory are spared (Tamminga et ah, 2010).
The hippocampus is located in the posterior half of the brain, within the medial
temporal lobe, which contains the hippocampal formation, perirhinal, parahippocampal
and entorhinal cortices. The hippocampal formation itself is composed of two
interlocking C shapes as well as the subiculum; the pyramidal cells of comu ammonis 1-3
(CA1-3 or hippocampus proper) form one C and the granule cells of the dentate gyrus
(DG) form the opposing C (Bliss and Lomo, 1973). The most superficial layer of the
CA1-3 region (also known as Ammon’s hom) is the alveus (containing axons of
pyramidal neurons leaving the hippocampus), followed by the: stratum oriens (a mixture
of fibres and intemeurons), stratum pyramidale (cell bodies of pyramidal cells), stratum
lucidum (receives input from the DG, only present in CA3), stratum radiatum (contains
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apical dendrites of pyramidal neurons), and the stratum lacunosum-moleculare (contains
the apical tufts of dendrites of pyramidal neurons). In the dentate gyrus the lamination is
as follows, beginning superficially: the hilus (mixture of fibres and intemeurons), the
granule layer (cell bodies of granule cells), and stratum moleculare (Abraham et al.,
2010; Van Strien et al., 2009)
Polymodal association and sensory neocortex provide input into the
parahippocampal and perirhinal cortex, which in turn input to the entorhinal cortex which
provides the primarily input into the hippocampus via the perforant path, the first part of
the trisynaptic pathway. Information flows via the perforant path (from entorhinal cortex
to DG), the mossy fibres (DG to CA3) and the Schaffer collateral fibres (CA3 to CA1)
(Tamminga et al., 2010). Information exits the hippocampus from area CA1 back to the
entorhinal cortex, of course this is a very simplified model and it should be noted that in
reality the flow of information in the hippocampus is much more complex (see Figure
1.7).

1.14 Synaptic Plasticity
Synaptic plasticity is a change in the strength of a synapse that lasts hours or
upwards of days, and is thought to be the cellular basis for learning and memory.
Synaptic plasticity is bidirectional in that a synapse may either be strengthened as in
long-term potentiation (LTP) or weakened as in long term depression (LTD). Synaptic
plasticity was first demonstrated experimentally in the DG in 1966, it was later shown to
persist in anaesthetized rabbits and finally unrestrained, unanaesthetized rabbits (Bliss &
Lomo, 1973; Bliss & Gardiner-Medwin, 1973). However, this was certainly not the first
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time the idea had been proposed. As early as 1894 Ramon Y Cajal hypothesized that
learning involved cortical plasticity of pyramidal neurons (Jones, 1994). Some years
later in his 1949 book Donald Hebb proposed that if two cells repeatedly fire in
synchrony the connection between them will be strengthened. The idea of “Hebbian
learning” or a “Hebbian synapse” is one that still persists today (Cooper, 2005).
Synaptic plasticity occurs in many areas of the nervous system and can take on a
variety of forms. For example, even within the hippocampus the synaptic plasticity at
mossy fibre synapses is NMDAR independent, while the synaptic plasticity at Schaffer
collateral synapses is NMDAR dependant. This thesis focuses on Schaffer collateral
synaptic plasticity which is by far the most widely studied form of synaptic plasticity,
perhaps this is because NMDAR dependant plasticity of glutamatergic excitatory
synapses can be observed throughout the entire mammalian brain (Harris et al., 1984;
Malenka & Nicoll, 1999).

1.15 NMDAR Dependant Synaptic Plasticity
Strengthening or weakening of a synapse is achieved by altering the open
probability, channel conductance or number of AMPAR at the synapse; these processes
are all triggered by Ca entry though NMDAR.
CaMKII is necessary for the induction of LTP at NMDAR dependent synapses
such as the Schaffer collateral synapses of the hippocampus. When bound to GluN2A
tails of NMDAR, CaMKII is ideally positioned to detect calcium entry through the
NMDAR channel pore (Kennedy, 2000). Following the binding of calcium, CaMKII
phosphorylates GluRl subunits of AMPA receptors at the Ser831 site, located on the
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intracellular C-terminal tail, increasing the channel conductance. GluRl is one of the
most common AMPAR subtypes in the hippocampus (Oh & Derbach, 2005). There is
also evidence that the NMDAR calcium signal recruits new AMPAR to the cell
membrane (Shi et al., 1999).
It was long suspected that LTP and LTD were exact opposites; surprisingly this
seems not to be the case. The GluRl subunit is constitutively phosphorylated by cAMP
dependent protein kinase (PKA) at Ser845 located on the intracellular C-terminal tail,
under basal conditions. Evidence suggests that LTD is the result of a calcium dependent
dephosphorylation of the Ser845 site which alters AMPAR open probability, likely via
protein phosphatase 1 (PP1) and calcineurin. Phosphorylation state may also affect the
rate with which AMPAR are internalized (Kameyama et al., 1998; Lee et al., 1998; Lee et
al., 2000) (see Figure 1.4).
Given that both LTP and LTD are the result of calcium entry though NMDARs
one area of debate is what factors distinguish the induction of LTP from LTD.
Experimentally, LTP is induced by brief high frequency stimulation, while LTD is
induced by prolonged low frequency stimulation; leading many to believe that it is simply
the time-course and kinetics of the calcium signal which determines the direction of
plasticity (Yashiro et al., 2008). However, there is evidence to suggest that GluN2A and
GluN2B containing receptors may differentially regulate synaptic plasticity. Liu et al.
(2004) demonstrated that application of a GluN2B antagonist completely blocked the
induction of LTD and antagonizing GluN2A blocked the induction of LTP, leading to the
hypothesis that GluN2B containing receptors are necessary for LTD induction and
GluN2A containing receptors are necessary for LTP induction. The finding that GluN2A
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and GluN2B receptors differentially coupled to kinases and phosphatases, such as
CaMKII lends support to this hypothesis (Kennedy, 2000). Several groups have not been
able to replicate Liu et al.’s results and suggest the alternative hypothesis that changes in
the GluN2A/B ratio determine the direction of plasticity (Morishita et al., 2006).
The model of LTP and LTD presented is somewhat simplified. The possibility of
a retrograde transmitter affecting presynaptic transmitter release is not discussed. It
should also be noted that late-phase LTP (potentiation beyond three hours) requires gene
transcription and the synthesis of new proteins (Gong et ah, 2011). The work in this
thesis pertains to postsynaptic early phase NMDAR dependent synaptic plasticity.

1.16 Metaplasticity
The term ‘metaplasticity’ is based on the Bienenstock-Cooper-Munro (BCM)
model, a mathematical model for the development of neuron selectivity in the visual
cortex. Basically, the model proposes that changes in the efficacy of a synapse depend
not only on current pre and post synaptic activity but on prior patterns of postsynaptic
activity (Bienenstock et ah, 1982). Abraham and Bear were the first to pioneer the term
metaplasticity. ‘Meta’ is a Greek prefix meaning above or beyond, so metaplasticity is
meant to refer to a level of plasticity above synaptic plasticity (Abraham & Bear, 1996).
To put it another way, metaplasticity refers to any mechanism which can alter the
threshold for induction of synaptic plasticity without altering basal synaptic transmission
(MacDonald et ah, 2007).
The BCM model can be altered to pertain specifically to extracellular
hippocampal slice recording. Frequency of stimulation used to induce plasticity is along
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Figure 1.4 Model of bidirectional synaptic plasticity in the CA1 region proposed by
Kameyama et al., 1998. This model is based on the serine phosphorylation of sites
Ser845 and Ser831 on the intracellular tail of the GluRl subunit of the AMPAR and the
four possible phosphorylation states of the AMPAR as a result (from Kameyama et al.,
1998)

26

the X axis and amplitude of LTP and LTD is along the Y axis. The shifting of this curve
either right of left is the result of metaplasticity (see Figure 1.5). One example can be
seen in hippocampal slices deprived of extracellular magnesium. The threshold for
induction of LTP is increased (shifted rightward); a higher frequency of stimulation
would be required to induce the same level of LTP as prior to the magnesium deprivation
(Coan et al., 1989). Within the hippocampus most signalling pathways which have
metaplastic effects converge on NMDARs, because they gate for the induction of
plasticity but contribute very little if at all the basal transmission.

1.17 Phosphatases, Kinases and NMDARs
Protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) within
the central nervous system are emerging as critical players in setting the threshold for
induction of synaptic plasticity. Phosphorylating NMDARs has been shown to alter
channel gating and the amplitude of NMDAR currents in vitro as well as increase
receptor trafficking to the postsynaptic membrane (MacDonald et al., 2007). In addition,
inhibition of endogenous PTKs has been shown to depress NMDAR currents, while
inhibition of endogenous PTPs potentiates NMDAR currents (Wang & Salter, 1994).
The main kinases involved are the Src family kinases (SFKs), five of which are
present in the mammalian central nervous system: Src, Fyn, Lck, Lyn and Yes (Kalia et
al., 2004). The prototypical family member, Src, was originally discovered as a proto
oncogene (Stehelin et al., 1976). Src family kinases are controlled by two
phosphorylation sites, an autophosphorylation site (Y416 in Src) and a regulatory
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Figure 1.5 BCM model of metaplasticity altered to correspond to extracellular
hippocampal slice recordings. The X axis corresponds to the stimulation frequency used
to induce plasticity (tetanus). The Y axis indicates the degree of LTP or LTD. 0
indicates the point at which a shift from LTD to LTP occurs. The figure illustrates how
Gaq coupled GPCRs are hypothesized to shift the BCM curve leftward, facilitating LTP
(modified from Sidhu, 2009). *0 (theta) in this thesis refers specifically to the BCM
curve and is not to be confused with hippocampal theta rhytynms
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phosphorylation site (Y527 in Src). Dephosphorylation of the regulatory site coupled
with autophosphorylation is required for activation (Mainou & Dermody, 2011). Src is
part of the NRC and is able to phosphorylate GluN2A subunits via its interaction with
ND2. Src can be activated by Gaq coupled receptors such as muscarinic acetylcholine
receptors, and lysophosphatidic acid (LPA) receptors by means of a PLCP, DAG, PKC,
call adhesion kinase P (CAK.p/Pyk2) cascade (Lu et al., 1999, MacDonald et ah, 2007)
(see Figure 1.6). In contrast Fyn can be activated by a Gas, AC, cAMP, protein kinase A
(PKA) cascade and is able to phosphorylate GluN2B subunits once it dissociates from the
NRC scaffolding protein RACK1 (MacDonald et ah, 2007).
PTPs can both increase and decrease NMDAR currents. At least five known
PTPs, including PTPa, can activate Src by dephosphorylating its regulatory site (Grishin
et ah, 2005). While members of the striatal enriched tyrosine phosphatase (STEP) family
are known to be part of the NRC and to decrease NMDAR channel gating via direct
dephosphorylation of the receptor (Kalia et ah, 2004). PTPs have also been shown to be
activated by muscarinic acetylcholine receptors by means of a PLC, IP3, Ca , calmodulin
(CaM) cascade (Grishin et ah, 2005) (see Figure 1.6 B).

1.18 PA CAP and NMDA
Under different experimental conditions PACAP has been shown to enhance,
inhibit and have no effect on basal synaptic transmission at Schaffer collateral synapses.
It seems to be the consensus that very low concentrations of PACAP (0.05nM) potentiate
basal synaptic currents (Roberto & Brunelli, 2000; Roberto et ah, 2001; Mauro et ah,
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Figure 1.6 Schematic of how a GPCR can alter NMDAR function via phosphatases and
kinases A. A Gaq coupled GPCR phosphorylâtes GluN2 subunits by way of Src (from
MacDonald et al., 2007) B. Ml GPCRs may be able to activate phosphatases and kinases
depending on intracellular calcium levels (from Grishin et al., 2005).
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2003; Costa et al., 2009), while high concentrations of PACAP (lOnM-lpM) depress
basal synaptic currents (Kondo et al., 1997; Roberto et al., 2001; Circanna &
Cavallaro,2003; Costa et al., 2009). InM PACAP seems to have no effect on basal
synaptic transmission (MacDonald et al., 2005; Sidhu, 2009). Costa et al. (2009) propose
that this may be because at low concentrations PACAP will only activate the PAC1R
while at higher concentrations PACAP also activates the VP AC receptors, specifically
VPAC2 since they found a VPAC2 agonist mimicked many of the effects observed at
high concentrations of PACAP. These effects of PACAP on AMPARs seem to be
mediated by cAMP/PKA, but may also have a presynaptic or cholinergic component
(Costa et al., 2009).
Our group has shown that at a concentration of 1nM PACAP affects NMDARs
rather than AMPARs. Despite the fact that the PAC1R can signal through either Gas or
Gaq, PACAP’s effects on NMDAR currents are only through Gaq, PLC, DAG, PKC,
CAKp/Pyk2, and Src (MacDonald et al., 2005). Although the Ron group has proposed
that InM PACAP potentiates NMDA currents through Gas, cAMP, PKA, and Fyn
dissociation from RACK1 (Yaka et al., 2003), it has since been demonstrated that the
effects of peptide R1 which mimics the Fyn binding site on RACK1 and potentiates
NMDAR currents, can be blocked by the Src inhibitory peptide 40-58 (MacDonald et al.,
2007). This suggests that the effects observed by the Ron groups were actually mediated
by Src (for summary see Figure 1.7).
Most recently application of InM PACAP to hippocampal slices was found to
facilitate LTP at when the induction stimulus was 10Hz (Sidhu, 2009).
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Figure 1.7 Summary of the effects of manipulations of the PACAP system in different
areas of the hippocampus; pyramidal cells (Py), Schaffer collaterals (Sch), mossy fibres
(mf), granule cells (Gr), dentate gyrus (DG), perforant path (pp), induction of LTP (Î),
induction of LTD or impairment of LTP ( j) and no change (—►
) (modified from
Hashimoto et al., 2002).
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1.19 Rationale and Hypothesis
PACAP is able to facilitate LTP induced by stimulation at 10Hz and 20Hz but has
no effect after high frequency stimulation (50Hz and 100Hz) in hippocampal slices at
Schaffer collateral synapses. The PACIR specific antagonist M65 depresses LTP
following high frequency stimulation (100Hz) (Sidhu, 2009). Taken together these
results suggest that endogenous PACAP is active following high frequency stimulation
and contributes to LTP. This is not surprising since most neuropeptides are released in
response to high frequency stimulation or stressful events (Ogren et al., 2010). If
PACIR are already saturated with endogenous PACAP following high frequency
stimulation this would explain why InM exogenous PACAP has no effect, but a PACIR
antagonist does.
We proposed to investigate the endogenous release of PACAP at Schaffer
collateral synapses on LTP, first by confirming the effects of InM PACAP at
intermediate frequencies, and the effect of a PACAP receptor antagonist at high
frequencies and secondly, by investigating the plasticity of PACAP null mice at high
frequencies in comparison to their wildtype littermates. We suspect they will display
impaired LTP at Schaffer collateral synapses.
Our main hypothesis is that endogenous PACAP is active following high
frequency stimulation and contributes to LTP. We plan to further investigate the
hypothesis that exogenous PACAP can facilitate LTP induced by stimulation trains of 10
and 20Hz.

Section 2

MATERIALS & METHODS
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2.1 Hippocampal Slice Recordings
21-28 day old Wistar rats or 6-8 week old mice were anaesthetized with
isofluorane and immediately decapitated. Brains were quickly removed and submerged
in ice-cold, oxygenated (95%02/5% CO2) artificial cerebral spinal fluid (aCSF). The
aCSF was of the following composition (in mM): NaCl (124), KC1 (3), MgCl2(1.3),
CaCb (2.6), NaF^PCU (1.25), NaHCOi (26), and D-glucose (10), osmolarity adjusted to
305-310 mmol. Hippocampi were then removed and fixed onto a 3% agar block. 350pm
transverse hippocampal slices were cut using a vibrotome (VT1200S; Leica) and
transferred to a holding chamber. Slices were allowed to recover for at least one hour
submerged in room temperature, oxygenated aCSF.
For recording, slices were transferred to a submersion-type recording chamber
and held in place by a wire grid. 30-31°C oxygenated aCSF continuously flowed over
the slices at a rate of 3mL/min. Slices were given at least 10 minutes to adjust before
recording commenced. The stimulating electrode was a platinum/iridum concentric
bipolar electrode (75pm x 65mm, MicroProbes) placed in the stratum radiatum of area
CA3, roughly 50pm below the cell layer, on the surface of the slice. The recording
electrode was a glass electrode filled with aCSF, 3-5M D in resistance, placed in the
stratum radiatum of CA1, 50pm below the cell layer (see Figure 2.1). The depth of the
recording electrode was adjusted to obtain the maximum possible response but was
usually at ~175pm depth from the slice surface. Field excitatory postsynaptic potentials
(fEPSPs) were evoked via electrical stimulation (lOOps duration) of the Schaffer
collateral pathway (from CA3-CA1). Firstly, the input-output relationship of each slice
was measured by varying the intensity of stimulation between 10-lOOOpA. For all further
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recording the stimulation was then set to generate a fEPSP approximately 1/3 of the
maximum response measured before the onset of somatically generated population spike.
The stability of the slice was established for a period of 10 minutes at either 0.05 or
0.03Hz. Slices with an unstable fEPSP slope were discarded. Any drugs applied were
added to the aCSF and were present either for the duration of the recording, or for a 1030 minute segment of the recording, by means of switching to a different recording
solution. In all cases where plasticity was induced, it occurred following a 20 or 40
minute baseline period. Plasticity was induced by brief high-frequency stimulation
known as ‘tetanus,’ at a frequency of 10Hz (600 pulses), 20Hz (900 pulses) or 100Hz (4
trains of 1OOpulses with a 1.5 second inter-train interval). Recording continued for 60
minutes post-tetanus at a frequency of either 0.05 or 0.03Hz. Signals were amplified
using a Multiclamp 700B (Axon Instruments), sampled at 5KHz and analyzed using
Clampex software (version 9.2 Axon Instruments).

2.2 Animals
All animal experimentation was conducted in accordance with the policies on the
use of animals at the University of Western Ontario. PACAP wildtype and knock-out
animals were provided by Dr. Nancy M. Sherwood, University of Victoria. Samples of
tissue were taken from the animals’ ears and mixed with extraction master mix (Sigma)
by vortex. Samples were then incubated for 10 minutes at room temperature and 3
minutes at 95°C prior to polymerase-chain reaction (PCR). Genotype was identified
based on the expected bands for widltype (215 base pairs) and knock-out mice (-650
base pairs). Primers for YPCR were as follows 0.5pi, 4pM 5’-MPl Primer (5’-
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Figure 2.1 Photograph of recording set up. Transverse hippocampal rat slice held in
place by a wire grid with stimulating and recording electrodes positioned to stimulate
Schaffer collateral fibres and record the response in CA1.
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ATGTGTAGCGGAGCAAGGCTGG -3’), 0.5pl, 4pM 5’-PAl Primer (5’CACTCGGACGGCATCTTCACAGATAG -3’) and 0.5pl, 4pM 3’-MP2 Primer (5’GAACACGAGTGATGACTGGTCAGTC -3’). Wistar rats were obtained from Charles
River.
2.3 Drugs and Peptides
The sources of drugs for this study are as follows: PACAP (Tocris Bioscience),
maxadilan (Tocris Bioscience), PACAP 6-38 (Phoenix Pharmaceuticals Inc.), sodium
orthovanadate (Sigma-Aldrich), CNQX (Tocris Bioscience), bicuculine (Tocris
Bioscience). Sodium orthovanadate was prepared according to manufacturer’s
instructions.

2.4 Statistical Analysis
All population data are expressed as mean ± SEM. One way ANOVA
(Bonferroni or Tukey corrected for pair-wise comparisons) was used to compare multiple
groups. Two-way ANOVA (with the factors treatment/genotype and time) were used to
compare between two groups, as well as student’s t-test. Student’s t-tests were performed
on the average of the final five minutes of the post tetanus hour, or in the cases where
plasticity was not induced the final five minutes of drug application. Paired t-test was
used to compare within groups; the average of the first five minutes of recording versus
the final five minutes of drug application was measured. The significance level was held
constant at p < 0.05.

Section 3

RESULTS
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3.1 PACAP does not consistently cause LTP following 10 Hz stimulation
It has previously been demonstrated in hippocampal slices that InM PACAP,
administered for a period of 10 minutes preceding 10Hz stimulation, causes a shift from
LTD in control slices to LTP (Sidhu, 2009). To begin with, we set out to confirm this
result. Hippocampal slices were prepared as described above. Field EPSPS were evoked
at 0.05Hz for a period of 10 minutes. During a further 10 minutes of recording, InM
PACAP was administered via bath application, following which plasticity was induced
using repetitive stimulation delivered at 10Hz. We continued to record post-tetanus for
one hour at 0.05 Hz. We observed no consistent effect of PACAP on plasticity at this
concentration and duration of administration (p = 0.3190, control = 0.7744 ± 0.06962
N=4, InM PACAP = 0.8884 ± 0.1972 N=5; unpaired t-test) (Figure 3.1). We attempted a
variety of concentrations (lnM-21nM PACAP) and two different durations of drug
exposure (10 and 15 minutes); however the finding that InM PACAP facilitates LTP in
slice one hour after 10Hz stimulation was not consistently replicated.

3.2 Maxadilan decreases the amplitude of LTD via postsynaptic mechanisms
Exogenously applied PACAP acts on all three of PACAP's receptors (PAC1R,
VPAC1 and VPAC2), two of which do not couple strongly to the Gaq pathway which has
been demonstrated to phosphorylate GluN2A subunits and alter plasticity (Lu et al.,
1999). We hypothesized that we might be able to observe the reversal of LTD that has
been previously demonstrated using PACAP (Sidhu, 2009), by targeting the Gaq coupled
PAC1R specifically. Maxadilan is a specific agonist of the PAC1R. Using the drug
treatment regimen described earlier, maxadilan was bath applied, following which
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Figure 3.1 PACAP did not reverse LTD at 10Hz A. Application of InM PACAP (-10 to
0 minutes) did not consistently alter LTD, plasticity was induced at 10Hz, 600 pulses at
time 0 indicated by an arrow (p = 1.00 interaction time x treatment, p = 0.029 7treatment;
two-way ANOVA) (p = 0.3190, control = 0.7744 ± 0.06962 N=4, InM PACAP = 0.8884
± 0.1972 N=5, unpaired t-test). Data are expressed as mean ± SEM. B. Representative
traces from time 1 (-20 minutes) and time 2 (60 minutes) for control and InM PACAP.
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plasticity was induced at 10Hz. We continued to record post-tetanus for one hour at 0.05
Hz. While 1OnM maxadilan did not cause a reversal of LTD, we observed a significant
decrease in the amplitude of LTD post-tetanus compared to controls (p = 0.0133, control
0.5590 ± 0.07103 N=4; lOnM maxadilan 0.7762 ± 0.03821 N=9; unpaired t-test) (Figure
3.2).
It could be argued that maxadilan may be either altering the basal synaptic
transmission, or the presynaptic neurotransmitter release. These effects, rather than the
PAC1R, serine/threonine kinase, protein kinase C, Src cascade could be causing the
decrease in slope amplitude observed one hour post tetanus. In order to rule out these
possibilities we assessed the input-output relationship and paired-pulse facilitation, which
control for basal synaptic transmission and presynaptic transmitter release respectively.
Following a twenty minute baseline recording at 0.05Hz, during which lOnM maxadilan
was administered for the final ten minutes, input-output relationship and paired pulse
facilitation were assessed. To measure the input-output relationship we generated a series
of fEPSPs at increasing stimulus intensities 400-3000pA. Only slices with a visible
afferent fibre volley were included. The afferent fibre volley is the result of an action
potential occurring in presynaptic fibres. The peak of the afferent fibre volley generated
was measured and plotted on a scatter plot in relation to the slope of the corresponding
fEPSP. For each individual slice linear regression was performed and the resulting slope
values were averaged for control and maxadilan treated slices. No significant differences
were found between control and maxadilan treated slices. This illustrates that when an
equivalent number of presynaptic fibres are activated the application of 1OnM maxadilan
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for 10 minutes does not affect the slope of the flEPSP generated (p = 0.9028, control =
3.505 ± 0.3080 N=6, maxadilan = 3.562 ± 0.3330 N=6; unpaired t-test) (see Figure 3.3.)
To measure paired-pulse facilitation, two fEPSPs were evoked in sequence.
These fEPSPs were evoked at a stimulus intensity which generates approximately 1/3 of
the maximal fEPSP possible before a population spike. The time between these two
fEPSPs was measured in milliseconds and is referred to as the interpulse interval (IPI),
and was gradually increased each sweep (10, 20, 40, 80, 150, 300 and 500 ms). When
stimulation is delivered to a slice, an action potential invades the presynaptic fibre
causing voltage gated calcium channels to open. This presynaptic influx of calcium
triggers the release of neurotransmitter (mostly glutamate in this case). The smaller the
IPI the more residual calcium should be present as a result of the first pulse (PI) which
can then summate with calcium entering as a result of the second pulse (P2) causing
greater neurotransmitter release and a larger fEPSP. We measured the peak of the fEPSP
generated as a result of each pulse and plotted (peak of the fEPSP for P2) / (peak of the
fEPSP for PI). There was no significant difference between P2/P1 for any IPI. This
demonstrates that maxadilan has no effect on presynaptic neurotransmitter release (Figure
3.4).
Specifically activating the PAC1R causes reduced LTD. This is an indication that
the threshold for LTP is shifted leftward by activating the PAC1R. The input-output
relationship and paired pulse facilitation were also measured to control for differences in
synaptic efficacy and presynaptic transmitter release respectively. No differences were
found between control and maxadilan treated slices for either of these measures.
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Figure 3.2 Maxadilan attenuates LTD at 10Hz A. Application of lOnM maxadilan (-10 to
0 minutes) decreases the amplitude of LTD post-tetanus, plasticity was induced at 10Hz,
600 pulses at time 0 indicated by an arrow (p = 0.0085 interaction time x treatment,
p<0.0001 treatment; two-way ANOVA) (p = 0.0133 control 0.5590 ± 0.07103 n=4;
lOnM maxadilan 0.7762 ± 0.03821 N=9; unpaired t-test). Data are expressed as mean ±
SEM. * indicates p < 0.05 B. Representative traces from time 1 (-20 minutes) and time 2
(60 minutes) for control and lOnM maxadilan.
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Figure 3.3 Maxadilan has no effect synaptic efficacy A. Scatter plot of the fibre volley
amplitude against the fEPSP slope for each individual fEPSP generated. B. Linear
regression was performed and the resulting slope values were averaged for control and
maxadilan treated slices. No significant differences were found between control and
maxadilan treated slices (control = 3.505 ± 0.3080 N=6, maxadilan = 3.562 ± 0.3330
N=6, p = 0.9028, unpaired t-test). Data are expressed as mean ± SEM. C. Representative
traces of a series of fEPSPs generated for control and lOnM maxadilan.
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Figure 3.4 Maxadilan has no effect on presynaptic neurotransmitter release A. Peak of
the second fEPSP generated (P2)/ peak of the first fEPSP generated (PI) plotted against
the interval between the two fEPSPs (inter-pulse interval). There was no significant
difference between P2/P1 for any inter-pulse interval (unpaired t-test). Data are
expressed as mean ± SEM. B. Representative traces of a series of fEPSPs generated for
control and lOnM maxadilan.
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3.3 PACAP 6-38 has no effect on LTP following 100Hz tetanic stimulation
Following 10Hz stimulation we observed a decrease in LTD in slices treated with
1OnM maxadilan for 10 min, however we did not observe the reversal of LTD we might
have predicted from previous findings with PACAP (Sidhu, 2009). This discrepancy may
in part be due to the fact 10 Hz is in the theta range; the point at which a switch from
LTD to LTP occurs is known as ‘theta.’ A wide range of factors can affect specifically
where the theta value falls. For this reason we chose to focus on a higher frequency of
stimulation, further from the theta range.
Exogenously applied PACAP has been shown to mediate a reversal of LTD
following 10 and 20Hz stimulation, but has no effect following 50 or 100Hz simulation.
Interestingly, the specific PAC1R antagonist M65 (lpM bath applied for 10 minutes) can
attenuate LTP following 100Hz stimulation (Sidhu, 2009). Taken together these results
suggest that endogenous PACAP is active following high (50Hz or above) frequency
stimulation, rendering exogenously applied PACAP redundant and without effect at these
frequencies. Thus the metaplastic effects of pharmacological antagonism or genetic
deletion of PACAP would be most pronounced at higher frequencies due to endogenous
activity of PACAP. We set out to test this hypothesis using a non-specific PACAP
antagonist, PACAP 6-38. Field EPSPs were evoked at a frequency of 0.05Hz for a
period of 10 minutes at which point unstable slices were discarded. Following a further
10 minutes of recording, during which lOnM PACAP 6-38 was administered via bath
application, plasticity was induced at 100Hz. We continued to record post-tetanus for
one hour at 0.05 Hz. We observed no significant change in fEPSP slope in PACAP 6-38
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treated slices compared to control slices (p = 0.2623, control=1.183 ± 0.08139 N=9,
lOnM PACAP6-38=1.256 ± 0.05875 N=6; unpaired t-test) (Figure 3.5).

3.4 PACAP Knock-outs display attenuated LTP at 100 Hz
While pharmacological data using PACAP 6-38 did not support our hypothesis
that endogenous PACAP is active following high frequency stimulation, we chose next to
further investigate this hypothesis using a genetic manipulation of the PACAP system.
We obtained mice homozygous for a targeted deletion of PACAP (PACAP knock-out
(KO)) in order to test the amplitude of their LTP following 100Hz stimulation in
comparison to their wildtype littermates (Gray, 2001). We predicted that PACAP knock
outs should display decreased LTP following high frequency stimulation in comparison
to wildtype littermates. We employed the same 100Hz stimulation protocol as described
above and we observed impaired LTP in the PACAP knock-out mice compared to
controls (p = 0.0241, wildtype=2.229 ± 0.1855 N=6, PACAP KO=1.735 ± 0.1179 N=6;
unpaired t- test) (Figure 3.6). Input-output relationship (protocol described above) was
measured to control for developmental differences in synaptic efficacy and no differences
were observed between knock-outs and their wildtype littermates (p = 0.0241,
wildtype=2.229 ± 0.1855 N=6, PACAP KO=1.735 ± 0.1179 N=6; unpaired t- test)
(Figure 3.7).

3.5 InMPACAP does not increase NMDAR-fEPSPs
Field EPSPs, are almost entirely AMPAR mediated, however NMDARs are the
receptors which gate the induction of synaptic plasticity. We hypothesized that activating
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Figure 3.5 PACAP 6-38 has no effect on plasticity at 100Hz A. Application of 1OnM
PACAP 6-38 (-10 to 0 minutes) has no effect on LTP post-tetanus, plasticity was induced
at 100Hz, 4x100 pulses at time 0 indicated by an arrow (p = 1.00 interaction time x
treatment, p = 0.0946 treatment; two-way ANOVA) (p = 0.2623, control-1.183 ±
0.08139 N=9, lOnM PACAP6-38=1.256 ± 0.05875 N=6; unpaired t-test). Data are
expressed as mean ± SEM.B. Representative traces from time 1 (-20 minutes) and time 2
(60 minutes) for control and lOnM PACAP 6-38.
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Figure 3.6 PACAP knock-outs display attenuated LTP A. Knock-out mice displayed
significantly attenuated LTP compared to wildtype littermates, plasticity was induced at
100Hz, 4x100 pulses at time 0 indicated by an arrow (p = 0.6592interaction time x
treatment, p<0.0001 genotype; two-way ANOVA)(p = 0.0241, wildtype=2.229 ± 0.1855
N=6, PACAP KO=1.735 ± 0.1179 N=6; unpaired t- test). Data are expressed as mean ±
SEM. B. Representative traces from time 1 (-20 minutes) and time 2 (60 minutes) for
wildtype and PACAP knock-out mice.
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Figure 3.7 Genetic deletion of PACAP has no effect synaptic efficacy A. Scatter plot of
the fibre volley amplitude against the fEPSP slope for each individual fEPSP generated
B. Linear regression was performed and the resulting slope values were averaged for
wildtype and PACAP knock-out mice. No significant differences were found between
wildtype and knock-out mice (wildtype = 14.38 ± 4.550 N=9, control = 9.472 ± 1.885
N=5, p = 0.4558 unpaired t-test). Data are expressed as mean ± SEM. C. Representative
traces of a series of fEPSPs generated for wildtype and PACAP knock-out mice.
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the PAC1R alters the conductance ofNMDA receptors resulting in changes in AMPAR
number or conductance and therefore plasticity. Given our difficulty demonstrating that
altering the PACAP system can affect synaptic plasticity, we decided to narrow our focus
to isolated NMDAR-mediated fEPSPs (NMDAR-fEPSPs). lOpM bicuculine (GABA
antagonist) and 20pM CNQX (AMPA antagonist) were present in the aCSF, for the
entire duration of the recording. Field EPSPs were evoked at a frequency of 0.03Hz.
Recordings lasted for a period of 30 minutes, InM PACAP was bath applied from 10
minutes-20 minutes. NMDA fields did not increase during the 10 minutes InM PACAP
was administered (p=0.4756, control = 1.049 ± 0.09063 N=3, InM PACAP=1.044 ±
0.02539 N=4; unpaired t-test) (Figure 3.8).

3.6 PACAP in the presence o f sodium orthovanadate increases NMDAR-fEPSPs
In their experiments studying PACAP’s effect on NMDAR function Yaka et al.
(2003) bath applied 10pM sodium orthovanadate (Na3V04), a phosphatase inhibitor,
during field recordings from rat and mouse hippocampal slices for 30 minutes before
application of drugs. Interestingly, Grishin et al (2005) found that in CA3 pyramidal
cells an Ml mediated depression ofNMDA receptor currents could be converted to a Src
mediated enhancement ofNMDA receptor currents in the presence of Na3V04. Grishin
and colleagues proposed a Gaq dual armed pathway in which one arm leads to a Src
mediated phosphorylation of NMDAR and an increase in their activity, while the other
arm leads to a phosphatase mediated dephosphorylation of NMDAR and a decrease in
their activity. They suggest intracellular calcium levels and kinetics are responsible for
determining which arm of the pathway is favoured.
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Figure 3.8 PACAP has no effect on NMDAR-fEPSP A. PACAP was administered from
10-20 minutes, there was no significant difference between control and PACAP treated
slices (p = 0.8910 interaction time x treatment, p = 0.6365 treatment; two-way ANOVA)
(p=0.4756, control= 1.049 ± 0.09063 N=3, InM PACAP=1.044 ± 0.02539 N=4; unpaired
t-test for final 5 minutes of PACAP administration). Data are expressed as mean ± SEM.
B. Representative traces from time 1 (0 minutes) and time 2 (20 minutes) for control and
PACAP treated slices.
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We thus hypothesized that by blocking the phosphatase arm of this proposed dual
pathway we would be able to see the predicted enhancement of NMDAR-fEPSPs by
PACAP via the Gaq coupled receptor PAC1R. We repeated the above experiment;
however NajV04 was present in the aCSF during the duration of the experiment. This
time a modest but significant increase in NMDAR-fEPSPs was observed during 10
minute PACAP application (p = 0.0278, Na3V04= 1.002 ± 0.03741 N=7, NaaVCVlnM
PACAP=1.221 ± 0.07519 N=13, unpaired t-test) (Figure 3.9). We then increased the
application of PACAP from 10 to 30 minutes and eliminated the 10 minute washout
period. When the PACAP application was extended to 30 minutes the increase in
NMDAR-fEPSPs was more robust (p = 0.0199, baseline=0.9913±0.03026, InM PACAP
administration^.733±0.2693, paired t-test) (Figure 3.10).

3.7 PACAP in the presence o f NCI3 VO4 does not facilitate LTP at 10Hz
Following our success in demonstrating an increase in NMDAR-fEPSPs by
PACAP in the presence of NajVC^ we returned our focus to field EPSPs. We
hypothesized that in the presence of Na3V04 we would observe a PACAP mediated
reversal of LTD following 10Hz stimulation. Field EPSPs were generated at a frequency
of 0.03Hz for a period of 10 minutes at which point unstable slices were discarded. InM
PACAP was bath applied for either 10 or 30 minutes after which plasticity was induced at
frequency of 10Hz. lOpM Na3VC>4 was present for the duration of recording. We
continued to record post-tetanus for one hour at 0.03 Hz. Contrary to our hypothesis we
saw no difference between control and PACAP treated slices following either a 10
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Figure 3.9 PACAP increases NMDAR-fEPSP amplitude in the presence of Na3V04 A.
PACAP was administered from 10-20 minutes, Na3V04 was applied for the entire 30
minutes (p = 0.2265 interaction time x treatment, p = 0.0022 treatment; two-way
ANOVA) (p = 0.0278, Na3V 04=1.002 ± 0.03741 N=7, NA3VO4 and InM PACAP=1.221
± 0.07519 N=13, unpaired t-test for final 5 minutes of PACAP administration). Data are
expressed as mean ± SEM. B. Representative traces from time 1 (0 minutes) and time 2
(20 minutes) for Na3VC>4 and PACAP/Na3V04 treated slices.
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Figure 3.10 PACAP increases NMDAR-fEPSP amplitude in the presence of Na3V04 A.
PACAP was administered from 10-40 minutes, Na3V04 was applied for the entire 30
minutes (p = 0.0199, baseline = 0.9913±0.03026, InM PACAP administration =
1.733±0.2693, paired t-test). Data are expressed as mean ± SEM. B. Representative
traces from time 1 (0 minutes) and time 2 (40 minutes) for Na3V04 and PACAP/Na3V04
treated slices.
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(p = 0.3230, Na3VO4=0.8754 ± 0.03491 N=8, Na3V 04/lnM PACAP= 0.8427 ± 0.05585
N=10; unpaired t-test) (Figure 3.11) or 30 minute pre-tetanus application (p =0.3021,
Na3V 0 4l=0.7803 ± 0.07365 N=6, Na3V 04/lnM PACAP=0.8340 ± 0.06439 N=5;
unpaired t-test) (Figure 3.12).

3.8 PA CAP in the presence o f Na3 V(> 4 facilitates LTP at 20Hz
As mentioned previously, 10Hz is in the range of frequencies where we observe a
shift from LTD to LTP which may explain the variability of some of the results observed
at this frequency. For this reason we recorded in the presence of 1OpM Na3V 04 and
tetanised at 20Hz. We hypothesized that we might be able to observe a reversal of LTD
more easily, further from the theta value. 10pM Na3V 04 was present during the duration
of the experiment. Field EPSPs were generated at a frequency of 0.03Hz for a period of
10 minutes at which point unstable slices were discarded. InM PACAP was bath applied
for 30 minutes after which plasticity was induced at frequency of 20Hz. We continued to
record post-tetanus for one hour at 0.03 Hz. We observed a significant facilitation of
LTP under these conditions (p=0.0335, lOuM Na3VO4=0.9572 ± 0.04176 N=4, lOuM
Na3V 0 4/lnM PACAP=1.257 ± 0.08342 N=4; unpaired t-test) (Figure 3.13).
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Figure 3.11 PACAP in the presence of Na3V04 has no effect on LTD at 10Hz A.
PACAP was applied from -10-0 minutes, plasticity was induced at 10Hz, 600 pulses at
time 0 indicated by an arrow (p = 1.00 interaction time x treatment, P<0.0001 treatment;
two-way ANOVA) (p = 0.3230, Na3VO4=0.8754 ± 0.03491 N=8, Na3V 04/lnM PACAP=
0.8427 ± 0.05585 N=10; unpaired t-test). Data are expressed as mean ± SEM. B.
Representative traces from time 1 (-20 minutes) and time 2 (60 minutes) for control and
PACAP treated slices.
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Figure 3.12 PACAP in the presence of Na3V04 has no effect on LTD at 10Hz A.
PACAP was applied from -30-0 minutes, plasticity was induced at 10Hz, 600 pulses at
time 0 indicated by an arrow (p=l .00 interaction time x treatment, p = 0.0025 treatment;
two-way ANOVA) (p =0.3021, Na3V 04=0.7803 ± 0.07365 N=6, Na3V 04/lnM
PACAP=0.8340 ± 0.06439 N=5; unpaired t-test). Data are expressed as mean ± SEM. B.
Representative traces from time 1 (-40 minutes) and time 2 (60 minutes) for Na3V04 and
Na3VC>4 /PACAP treated slices.
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Figure 3.13 PACAP in the presence of Na3VC>4 facilitates LTP at 20Hz A. PACAP was
applied from -30-0 minutes plasticity was induced at 20Hz, 900 pulses at time 0 indicated
by an arrow (p = 0.0267 interaction time x treatment, p<0.0001 treatment; two way
ANOVA) (p=0.0335, lOuM Na3V 04= 0.9572 ± 0.04176 N=4, lOuM Na3V 04/lnM
PACAP = 1.257 ± 0.08342 N=4; unpaired t-test). Data are expressed as mean ± SEM. *
indicates p < 0.05 B. Representative traces from time 1 (-40 minutes) and time 2 (60
minutes) for Na3V 04 and Na3V 04/PACAP treated slices.

Section 4

DISCUSSION
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4.1 Summary o f Key Findings
The basic aim of this thesis was to shed light on the role endogenous PACAP
plays in NMDAR dependant plasticity in the CA1 region of the hippocampus. Our
hypothesis that endogenous PACAP is active following high frequency stimulation was
supported by our slice recordings from PACAP KO mice. However we experienced
some difficulty finding support for this hypothesis in wildtype rats. Following this
difficulty in attenuating LTP with a PACAP antagonist and replicating the facilitation of
LTP by activating the PAC1R we were led to investigate a second PAC1R pathway
affecting plasticity. These two PAC1R pathways act in opposition to each other in terms
of their effects on plasticity. Once we inhibited the phosphatase arm of the pathway the
predicted facilitation of LTP by PACAP at an intermediate frequency was observed (see
Figure 4.1). Key findings are summarized here:
1) PACAP KO mice display attenuated LTP following high frequency stimulation of
Schaffer collateral fibres.
2) PACAP only potentiates NMDAR mediated fEPSPs in the presence of the
phosphatase inhibitor Na3V04.
3) PACAP will only facilitate LTP at an intermediate frequency in the presence of
Na3Y 0 4.

4.2 Determinant o f Favoured Pathway
It has been previously demonstrated that activation of a number of Gaq coupled
receptors, including muscarinic receptors, LPA receptors (Lu et al., 1999), the PAC1R
(MacDonald, 2005; Sidhu, 2009) and metabotropic glutamate receptors (Grishin et al.,
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Figure 4.1 Summary of results; all data are expressed as mean + SEM for the final five
minutes of drug application or for final five minute of post tetanus hour A. Experiments
measuring NMDA mediated fEPSPs. A one-way ANOVA p = 0.0044, Tukey multiple
comparison follow-up test* indicates p <0.05 compared to control. B. No groups differ
significantly from one another, p = 0.3198 one-way ANOVA. C. IOuM Na3V04 InM
PACAP compared to IOuM Na3V04 alone, p = 0.0092; unpaired t-test. D. p = 0.0001
one-way ANOVA, Bonferroni corrected. ** indicates p< 0.05 compared to wildtype.
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2004) potentiate NMDAR currents. In the case of the PAC1R this potentiation of
NMDAR currents has even been shown to extend to a facilitation of LTP at the
intermediate frequencies 10 and 20Hz (Sidhu, 2009). We were unable to consistently
replicate this well-established phenomenon until we recorded in the presence of Na3VC>4,
a broad-spectrum phosphatase inhibitor. For some reason under our experimental
conditions presumably one or more phosphatases were active that were not active when
previous work was conducted. Grishin et al. (2005) observed a muscarine induced
depression of NMDAR currents during whole cell recordings from CA3 pyramidal cells
under basal conditions. They were able to convert this depression to a Src mediated
potentiation, by recording in the presence of Na3VC>4.
In a previous experiment by Grishin et al. they produced the same conversion
from depression of NMD A current by muscarine (and DHPG a metabotropic glutamate
receptor agonist) in CA3 pyramidal cells to potentiation, only this time they achieved the
conversion by increased buffering of intracellular calcium (2004). In contrast in CA1
pyramidal cells they observed an initial potentiation of NMD A currents by muscarine and
DHPG which could be converted to a depression by a decrease in intracellular calcium
buffering (Grishin et al., 2004). Total intracellular calcium buffering activates neither
pathway, as both require calcium (Grishin et al., 2004). The potentiating pathway is the
well established PLCP, DAG, PKC (PKC is a calcium dependant protein), CAKp/Pyk2,
Src cascade (MacDonald et al., 2007), while the depressing pathway has been proposed
as PLC, IP3, Ca2+, CaM, and a PTP (Grishin et al., 2005).
Grishin et al. (2004) proposed calbindin-D28K as a potential mechanism for the
differing effects observed in CA3 and CA1 pyramidal cells. Calbindin chelates
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intracellular calcium and is expressed in CA1 but not CA3 cells (Sloviter, 1989). Grishin
et al (2004). did observe a comparable increase in intracellular calcium levels in response
to extracellular calcium increase, seeming to oppose the calbindin hypothesis, but
calbindin’s action may be more apparent in micro-domains as opposed to in global Ca2d"
levels making the hypothesis still valid.

4.3 Conservation of Gaq signalling to NMDAR
The LTP facilitating PLCP, DAG, PKC, CAKp/Pyk2, Src cascade has been well
established in the hippocampus. It can be activated by PACIRs (MacDonald et al., 2005;
Sidhu, 2009), LPA receptors (Lu, 1999), Ml receptors (Lu et al., 1999; Grishin et al.,
2005), and mGluR5 receptors (Kotecha et al., 2003; Grishin et al., 2004). It seems
strange that the hippocampus would have evolved such redundancy in signalling. The
possibility exists that the ability to potentiate NMDAR currents is so vital that multiple
pathways have evolved. This seems reasonable given that NMDARs are important for
neuronal development. The ability to potentiate NMDAR currents may be essential when
transforming silent synapses (synapses lacking AMPAR) into functional ones
(Dingledine et al., 1999). NMDARs are of course necessary for the induction of
plasticity in the CA1 region of the hippocampus, which is likely tied to learning and
memory processes. While all these receptor cascades terminate at the same endpoint,
NMDARs, they may serve very different purposes based on their spatial and temporal
activation. For example, we suspect that PACAP is released in response to highfrequency stimulation, whereas glutamate, which activates mGluR receptors, is released
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in response to a presynaptic action potential (Featherstone, 2010). These sorts of
temporal differences may explain the apparent redundancy in signalling.
However, multiple signalling pathways may be stimulated simultaneously
depending on the concentration of transmitter in the synaptic cleft and while Gaq
signalling may seem redundant, this NMDAR potentiation may summate with the effects
of other pathways. In this way PACAP, LPA, acetylcholine and glutamate may all have
very different downstream effects on NMDAR. We know the PAC1R is able to signal
through Gas as well as Gaq, as well PACAP can activate the VPAC1 and VPAC2
receptors (Vaudry, 2000). Similarly acetylcholine activates five metabotropic receptors
(Havekes et al., 2001), glutamate activates eight metabotropic receptors (Nicoletti et al..,
2011) and LPA activates six metabotropic receptors (Hama & Aoki, 2010). Perhaps the
particular receptor cocktail at a synapse determines the varying effects of these
transmitters on synaptic transmission.
The Gaq dual signalling pathway was first identified using DHPG and muscarine
and has been demonstrated in this thesis using PACAP (Grishin et al., 2004). While this
Gaq dual pathway is a relatively recent discovery receptors have been shown previously
to be capable of stimulating opposing pathways. Ml receptors have been shown to
bidirectionally modulate Kvl.2 potassium channels by means of a PTP and PTK. Tsai et
al. (1999) found that the phosphorylation of Kvl.2 by Ml could be enhanced in the
presence of a broad-spectrum phosphatase inhibitor. Upon further investigation this
phosphatase was identified as receptor tyrosine phosphatase a and was also found to be
activated by M l. M l, M3 and M5 have also been found to activate dual opposing
pathways in presynaptic nerve terminals. These receptors have been shown to stimulate
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Cav2.3 subunits of R-type calcium channels by means of a DAG, Ca independent PKC
pathway. In contrast the GPy subunit of these receptors inhibits these subunits. Similar
to the Gaq-NMDAR dual pathway, one arm of the pathway could be enhanced by
blocking the other. Muscarinic inhibition of Cav2.3 was enhanced by pharmacological
inhibition of PKC (Bannister et al., 1999).
These dual pathways likely exist as sort of internal regulatory mechanisms so that
no one pathway gets out of control. Metaplasticity in general, but more specifically these
opposing pathways likely function to keep the cell within an optimal range of synaptic
strength. It has been well established that excess calcium entry through NMDAR can
result in excitotoxicity (Meldrum, 2000). Without any sort of negative feedback, the
entry of calcium into the post synaptic cell would further depolarize the cell leading to
greater NMDAR activation in a positive feedback loop until the elevated calcium levels
resulted in cell death. Ca

is known to trigger phosphatases which depress NMDAR,

and this Gaq PTP pathway triggered by increased intracellular calcium may serve as a
secondary system of negative feedback to guard against excitotoxicity (Liu et al., 2007).
Alternatively we can also imagine a situation where LTD becomes amplified to
the point where the synapse is transformed into a silent synapse. It is perhaps for this
reason that when intracellular calcium levels are low the potentiating pathway is
favoured. This dual pathway system may act to provide balance and help the cell to
avoid excitotoxicity or the possibility of becoming a silent synapse and maintain the cell
in the optimal range for learning and memory.

4.4 Stress and Synaptic Plasticity
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Stress level of animals may be a factor affecting results. According to the work of
Grishin et al. (2004) under basal physiological conditions activating Gaq coupled
receptors, such as the PAC1R, should result in a depression of NMDAR currents in CA3
cells and a potentiation of NMDAR currents in CA1 cells. However, in our experiments
we were recording the field response from a group of CA1 pyramidal cell dendrites, and
we observed no change in NMDA mediated fEPSP in response to PAC1R activation.
Evidence strongly suggests that intracellular calcium level is the main determinant of
what effect activating Gaq coupled receptors will have on NMDARs. Taken together this
seems to indicates that the CA1 pyramidal cells in our experiment had calcium levels
elevated above normal physiological levels, although not high enough to favour a Gaq
induced depression of NMDA currents, just high enough to not affect NMDA currents.
We also know that a complete lack of calcium precludes any effect of Gaq coupled
receptors on NMDA currents, so we might hypothesize that the CA1 pyramidal cells in
our experiment completely lacked intracellular calcium, but this seems unlikely given
that we were able to restore potentiation by inhibiting PTPs, indicating the action of the
potentiating arm of the pathway could be unmasked by blocking the depressing arm.
Both arms of the pathway require calcium (Grishin et al., 2004).
This leads to the question of what mechanisms might drive an intracellular
increase in calcium slightly above normal physiological levels in CA1 pyramidal cells.
One likely candidate is stress. Glucocorticoids (cortisol and corticosterone) are steroid
hormones released from the adrenal cortex (Setiawan et al., 2007; Takahashi et al., 2002).
Basal levels of glucocorticoids can be beneficial during development; they are
responsible for neuronal survival, differentiation and structural and functional

68

development of synapses (Setiawan et al., 2007). Even in adulthood low levels of
glucocorticoids have been shown to enhance LTP (Takahashi et al., 2002). However,
during stressful events higher levels of glucocorticoids are released and at high doses
glucocorticoids have been shown to facilitate LTD, impair LTP and impair performance
on certain memory tasks (Takahashi et al., 2002).
Glucocorticoids act on two receptors, the mineralocorticoid receptors (MRs) and
glucocorticoid receptors (GRs), both are nuclear receptors that when bound by a ligand
affect gene transcription. Both these receptors are found in high concentrations in the
CA1 region of the hippocampus (Gerges et al., 2004). The MRs have a 10 times greater
bonding affinity for glucocorticoids than GRs, and thus mediate the response at basal
levels. During stress the high concentration of glucocorticoids saturates MRs and as a
consequence GRs are simultaneously activated. While activation of MRs favours LTP
and has a neuroprotective effect, activation of GRs impairs LTP (Nair et al., 1998).
Notably, in regards to the work in this thesis, glucocorticoids have been found to
affect calcium homeostasis. Nair et al. (1998) exposed animals to varying levels of
corticosterone and then examined the expression level of proteins which regulate calcium
influx and calcium-mediated synaptic plasticity using single-cell antisense RNA
amplification and expression profiling. One of their key findings was that chronic
exposure to high corticosterone levels lead to increased expression of proteins
contributing to P/Q and L-type calcium channels in CA1 neurons. Based on this finding
stress is a potential mechanism by which intracellular calcium levels in the experiments
outlined in this thesis were slightly elevated.
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4.5 Theta Value
If a slightly increased intracellular calcium level were the only difference in
condition between this experiment and the previous experiments where the PACIR was
shown to facilitate LTP at 10Hz, then we should have been able to observe a facilitation
of LTP in the presence of Na3VC>4by PACAP at 10Hz (Sidhu, 2009). This was not the
case; we needed to increase our stimulation to 20Hz in order to see the facilitation of LTP
by PACAP in the presence of NajVCTt that we predicted. One possible explanation for
this is that the theta value, the point at which we observe a shift from LTD to LTP, was
shifted rightwards in our experiments in comparison to the previous experiment. We have
already discussed how stress can affect calcium homeostasis in the CAI region of the
hippocampus, but this is by no means the only effect of stress in this area. Stress has a
multitude of effects on the hippocampus which taken together may shed some light on
why the theta value seems to be shifted rightwards in our present set of experiments.
It has been established that stress facilitates low-frequency stimulation induced
LTD in the CAI region, disrupts the retrieval of spatial memory in the water maze and
impairs LTP (Wong et al., 2007). Wong et al. (2007) propose the mechanism for this is a
corticosterone induced increase in glutamate release, and decrease in glutamate transport
from the synapse. This accumulation of glutamate in the synaptic cleft is hypothesized to
spill over to extra-synaptic sites containing a higher ratio of GluN2B containing receptors
and facilitating LTD. This hypothesis is partially based on the fact that antagonizing
GluN2B containing NMDAR with the specific antagonist Ro25-6981 blocks the stress
induced facilitation of LTD (Wang et al., 2006). Also stress induced facilitation of LTD
can be mimicked by infusion of the glutamate transporter inhibitor DL-TBOA (Wong et
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al., 2007). This stress induced up-regulation of glutamate levels in the synapse and
potential spill-over to extra-synaptic sites may explain the apparent rightward shift of the
BCM observed in the present experiments in comparison to the previous experiment
demonstrating facilitation of LTP at 10Hz (Sidhu, 2009).
Another mechanism for stress induced impairment of LTP is a reduction in basal
levels of CaMKII. As previously described CaMKII is critical for the induction of LTP, it
is activated by intracellular calcium entering though NMDAR and phosphorylates
AMPAR, increasing their channel conductance. Gerges et al. (2004) psychosocially
stressed animals for a period of one month. Consistent with previous studies these
animals showed impaired high frequency stimulation induced LTP. Immunoblotting was
performed to determine what components of LTP in particular were impaired and it was
determined that stressed rats had lower levels of CaMKII, phosphorylated CaMKII (PCaMKII), calmodulin, PKC and increased levels of calcineurin. As well, the increase in
P-CaMKII following high frequency stimulation observed in control rats was not
observed in stressed rats, leading the authors to suggest that a reduction in P-CaMKII is
the main mechanism of stress induced depression of LTP.
These two hypotheses are not mutually exclusive. A number of factors may
accumulate to shift the BCM curve rightward. It is possible that stress results in an upregulation of glutamate and a down-regulation of P-CaMKII which together shift the
theta value.
We have not yet addressed why our rats may have a different stress level than
those in previous experiments. There are so many factors which can affect the stress level
of an animal it is nearly impossible to control for all of them. There are multiple methods

71

for inducing stress experimentally and even more ways to inadvertently affect the stress
level of an animal. Experiments measuring the effects of stress on synaptic plasticity
have induced stress psychosocially (regularly introducing animals not part of the
established social hierarchy) (Gerges et al., 2004), using glucocorticoid injections
(Setiawan et ah, 2007), using an elevated Plexiglas platform in a brightly lit room (Wong
et ah, 2007) and using prolonged restraint (Stroth & Eden, 2010). Conditions such as
noise level (Burwell & Baldwin, 2006), environmental enrichment (Kappeler & Meaney,
2010), disruption of light/dark cycle, sleep disturbance, periods of isolation
(Matuszewich et ah, 2007), cage cleaning frequency (Bum & Mason, 2008) and
frequency of handling (Shcmidt et ah, 2011) are just a few factors that affect the stress
level of rodents. Given the number of factors that can affect stress level it is entirely
conceivable that two facilities might induce different levels of stress.
There are of course other potential mediators of a rightward shift in the BCM
curve. Basically any signalling pathway which terminates on NMDAR or a downstream
mediator of LTP could be the cause. We suspected at one point that trace levels of zinc
in recording solutions might be the cause of this rightward shift. Trace levels of zinc
have been shown to selectively inhibit GluN2A containing NMDAR over GluN2B
containing NMDAR (Paoletti et ah, 1997). This sort of preferential inhibition could
cause impairment in LTP. To control for this possibility we recorded in the presence of
1OmM tricine, a zinc chelator, but observed no difference between control and tricine
treated slices in terms of hippocampal synaptic plasticity (data not shown). This of
course does not rule out the possibility of a different heavy metal contaminant since
others are known to act on NMDA (Gavazzo et ah, 2011; Xu et ah, 2010).
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4.6 Knock-outs
When reviewing the data obtained from PACAP KO mice compared to the data
obtained from rats, two striking differences are apparent. Firstly, we were able to observe
attenuation of LTP in PACAP KO mice versus wildtype mice but not when the PACAP
receptor antagonist PACAP 6-38 was applied to rat hippocampal slices. Secondly, the
amplitude of LTP in wildtype mice was much greater than that observed in control rats
(see Figure 4.1)
To address the first issue, it is possible genetic deletion represents a more
complete block of PACAP signalling than pharmacological manipulation. One
disadvantage of hippocampal slice recordings is that any agonist or antagonist must be
bath applied and we cannot ensure complete diffusion of this agent to the recording site.
Perhaps we might have observed an effect of PACAP 6-38 had we extended our
application time or applied a higher concentration. M65 was demonstrated to attenuate
LTP at a concentration of lpM. M65 is PAC1R specific while PACAP 6-38 is less
specific (Robberecht et al., 1992; Moro et al., 1999). In our experiment we applied
PACAP 6-38 at a concentration of lOnM; perhaps a higher concentration would have
yielded more positive results.
Another potential explanation is that, as we have already speculated, stress may
be altering the effects of PACAP in a number of ways. The mice used in our experiments
were housed in a separate room, on a separate floor of the animal facility from the rats
accessed exclusively by members of our group and animal facility staff. It is conceivable
that these differences in housing conditions might result in a lower level of stress in mice
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versus rats in these experiments. If this is the case it is unlikely any change in PACAP 638 application duration or concentration would yield different results in rats. This might
also account for the differences in LTP at 100Hz in wildtype mice versus control rats. In
previous experiments using Wistar rats, Sidhu (2009) demonstrated LTP of 1.48±0.03 in
control rats following 100Hz stimulation, whereas in our experiments control rats only
displayed LTP of 1.183 ± 0.08139, and wildtype mice displayed LTP of 2.229 ± 0.1855.
This further suggests that the BCM in our rats was shifted rightward, perhaps if this were
not the case more comparable levels of LTP might have been observed in rats and mice.
However, it should be noted Sidhu (2009) employed only one train of stimulation lasting
600 pulses, while we employed 4 trains each 100 pulses in duration.
The differences in LTP amplitude following 100Hz stimulation between rats and
mice may be attributable to species differences. It can be difficult to compare studies of
LTP potentiation in different species as a variety of stimulation protocols are employed.
Setiawan et al (2007) showed LTP of around 2 (normalized fEPSP slope) in juvenile
guinea pigs, however their stimulation protocol varied slightly from ours (two 500ms
trains with a 20s interval). Prakash et al. (2009) have shown different levels of LTP in
two different strains of rats using the same stimulation protocol under the same
experimental conditions (1.8236± 0.18.96 vs. 1.665±0.02). If different strains of the
same species can exhibit such marked differences in LTP under identical experimental
conditions, surely differences must exist between species that might account at least in
part for the differences we observed between rats and mice in LTP amplitude.
We might have suspected that VIP, being able to signal through the same
receptors as PACAP with different affinity, may have compensated for the genetic
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deletion of PACAP (Vaudry et al., 2000). At least in terms of synaptic plasticity in the
CA1 region this seems not to be the case. Perhaps this is because PACAP’s contributions
to synaptic plasticity are somewhat limited. While deficits have been demonstrated
multiple times in the hippocampal fear conditioning task in PACAP KOs, these mice
have consistently shown no deficits in the Morris water-maze, a hippocampal spatial task
(Sauvage et al., 2000). We believe that this is because endogenous PACAP only
contributes to the upper end of the BCM, and while this results in definite deficits in
some hippocampal memory tasks it by no means affects all hippocampal tasks.

4.7 Future Directions
As mentioned previously LTP and LTD were thought to be directly opposing
processes. In other words, if LTP was the result of phosphorylation of Ser831 on GluRl
subunits, then LTD was assumed to be the dephosphorylation of that same site. Contrary
to this hypothesis a much more complex picture of synaptic plasticity is emerging. It
seems that the GluRl AMPAR subunit has at least four phosphorylation states each
possessing different open probabilities and channel conductance levels (Kameyama et al.,
1998). Three residues have been identified on the GluN2A cytoplasmic C-terminal tail
which are phosphorylated by SFKs (Y1292, Y1325 and Y1387), it would be interesting
to uncover whether the PTP involved in the negative arm of this Gaq pathway
dephosphorylates one of these three residues or whether it acts on an entirely separate
site. This might help us identify how many distinct phosphorylation states exist in
NMDARs pertaining to synaptic plasticity and what the different open probabilities and
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channel conductance levels of each state are, as well as perhaps identify what the basal
state of NMDAR is.
A broad spectrum inhibitor of PTPs was used to block the negative arm of the
pathway in all experiments to date. Grishin et al. (2005) have shown that this PTP is
acting directly on NMDAR rather than indirectly by deactivating Src, because muscarine
induced depression was unaffected by SFK inhibition. Roughly 100 PTPs have been
identified in the human genome. We can of course narrow our field to those that are
expressed in the hippocampus and those which we know to act on NMDAR. STEP
seems like one of the more likely candidates. As evidenced by its name (striatal enriched
tyrosine phosphatase) STEP is expressed in the highest levels in the striatum, however it
is also expressed in the hippocampus, neocortex, and amygdala. STEP
coimmunoprecipitates with NMDAR subunits and has been shown to interact directly
with them, which places STEP in a good location to modulate NMDAR function.
Microinfusion of STEP has been shown to block the induction of LTP at Schaffer
collateral synapses. In single channel recordings STEP has been shown to decrease open
probability and mean channel-open time of NMDAR. Conversely, an inhibitory STEP
antibody increased the NMDAR mediated portion of synaptic responses (Braithwaite et
al., 2006b). Chronic inhibition of STEP using short interfering RNA was also found to
increase NMDAR surface expression and NMDAR Ca currents (Braithwaite et al.,
2006a).
However, STEP has been proposed to preferentially modulate GluN2B containing
receptors, making it a less than ideal candidate to oppose the GluN2A mediated Src
response. An increase in intracellular calcium activates calcineurin, which activates
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STEP which either dephosphorylates GluN2B receptors at Y 1472 and/or deactivates Fyn
preventing it from phosphorylating Y 1472. The phosphorylation of Y1472 is required
for NMDAR trafficking to the postsynaptic membrane. However, alteration in receptor
trafficking does not explain the single channel recording data where STEP was shown to
decrease open probability and conductance time. Furthermore this pathway was
identified using P-amyloid acting on a-7 nicotinic receptors to increase Ca levels
(Synder et al., 2005). P-amyloid is a peptide which is elevated in Alzheimer’s disease
and perhaps under basal conditions this may not be the main pathway by which STEP
modulates NMDAR function. In addition STEP has been shown to coimmunoprecipitate with GluNl, GluN2A and GluN2B subunits (Braithwaite et al.,
2006a). Its ability to interact with all three main NMDAR subunits expressed in the
hippocampus makes it very unlikely that STEP’S effects are restricted to GluN2B
containing receptors. It remains possible that STEP acts on multiple subunits of the
NMDR, and is the PTP counteracting Src in the Gaq cascade.
Interestingly blocking calcineurin, a main component of the P-amyloid, STEP
cascade increased depression of NMDAR currents by muscarine (Grishin et al., 2005).
While both these pathways result in a down-regulation of NMDAR activity the P-amyloid
pathway is proposed to be GluN2B specific while the Gaq pathway is likely GluN2A
specific. Perhaps there is some competition between them and inhibiting calcineurin
frees up more Ca to activate calmodulin.
It would be easiest to investigate STEP’S involvement in this cascade in CA3
pyramidal cells since under basal conditions they seem to activate the negative arm of the
Gaq dual pathways (Grishin et al., 2004). It could also be investigated in CA1 pyramidal
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cells but we may need to decrease intracellular calcium buffering to ensure the negative
arm of the pathway is favoured. If STEP is the PTP in question, then infusion of
inhibitory STEP antibody should mimic the effect of NajVC^: convert the Gaq mediated
depression of NDMAR currents to a potentiation.
Besides identifying which PTP is involved another possible future avenue of
research is confirming the exact signalling cascade of the negative Gaq pathway. Grishin
et al. (2005) have proposed PLC, IP3, Ca2+, CaM, and a PTP, based on whole cell
recordings from CA3 pyramidal neurons in slice in which they selectively blocked each
step of their hypothesized pathway and NMDA currents were no longer depressed by
muscarine. These results need to be replicated in CA1 pyramidal neurons favouring the
negative pathway (by decreasing intracellular calcium buffering).
The hypothesis that stress increases intracellular calcium in CA1 pyramidal cells
and shifts the BCM rightward by up-regulation of glutamate and/or down-regulation of PCaMKII remains to be tested. Behavioural experiments are required to test this
hypothesis. Rats could be housed in three conditions high stress, control and low stress.
High stress rats would be subjected to a variety of stressors ranging from periodic food
and water deprivation, psychosocial stress, noise, disruption of light/dark cycle,
disruption of sleep, and time on an elevated platform. Ideally, low stress rats would be
housed in their own room with minimal noise, absolutely no disruption of their light/dark
cycle and environmental enrichment. Control rats would be housed under normal animal
facility conditions. Using extracellular hippocampal slice recordings of the Schaffer
collateral pathway we would then test a variety of intermediate frequencies. We would
predict that low stress rats would have a lower theta value than high stress rats. The theta
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value of control rats might help us to estimate the stress level of typical rats housed in our
animal facility. In addition we would expect that activating Gaq coupled receptors such
as LPA receptors, Ml receptors, PAC1R or mGluR5 receptors would result in a
depression of NMDA mediated fEPSPs in high stress rats and a potentiation in low stress
rats. We have already observed no change in NMDA mediated fEPSP in control rats (see
Figure 3.8). Finally, we might also probe for P-CaMKII levels in our three populations;
we would predict lower P-CaMKII levels in high stress rats versus low stress rats.
We were able to demonstrate the facilitation of LTP by PACAP at 20Hz in the
presence of Na3VC>4. Next it would be advantageous to demonstrate the facilitation of
LTP by the specific PAC1R agonist maxadilan at 20Hz in the presence of Na3V04. To
prove that this effect is via the Gaq, Src cascade.
Furthermore, we should test the effects of the PACAP receptor antagonists
PACAP 6-38 and M65 (PAC1R specific) in the presence of Na3V04. While PACAP 638 had no effect under basal conditions (see Figure 3.5), we would predict that PACAP 638 or M65 and Na3V04 would attenuate LTP at high frequencies versus Na3V04 alone,
but would have no effect at frequencies below 50Hz. This would provide further support
for our hypothesis that endogenous PACAP contributes to LTP at frequencies of 50Hz
and above. So far this hypothesis was supported by our finding of attenuated LTP in
PACAP KO mice at 100Hz (see Figure 3.6). In future the entire BCM for these mice
should be mapped out. Slice recordings should be performed inducing plasticity at a
variety of frequencies: 1,10, 20, and 50Hz. If our hypothesis is correct we would predict
no difference between KOs and wildtype littermates at 1, 10 or 20Hz, but attenuated LTP
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in KOs at 50Hz. These experiments could also be carried out in PAC1R specific KO
mice; we would expect the same results.

4.8 Overall Conclusions
In summary I have shown that PACAP KO mice display attenuated LTP, this
supports the hypothesis that endogenous PACAP contributes to LTP following high
frequency stimulation. Additionally I have provided evidence that PACAP, like DHPG
and muscarine (Grishin et al., 2004) can modulate NMDARs via two opposing pathways.
The positive pathway is the well characterized PLCfl, DAG, PKC, CAKp/Pyk2, Src
cascade (Macdonald et al., 2005), while the negative pathway has been proposed by
others to be PLC, IP3, Ca2+, CaM, and an unidentified PTP (Grishin et al., 2005).
Blocking the negative arm with NaaVCL allowed us to observed PACAP’s facilitation of
LTP at 20Hz.
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